Due to a production error, the funders “European Union's Horizon 2020 research and innovation programme” and “EFPIA” were erroneously omitted, as well as the disclaimer “This publication reflects the authors’ views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein”.
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
pediatric, drug development, networks, metrics, feasibility
Citation
Frontiers Production Office (2024) Erratum: Development and performance of the c4c national clinical trial networks for optimizing pediatric trial facilitation. Front. Pediatr. 12:1380274. doi: 10.3389/fped.2024.1380274
Received
01 February 2024
Accepted
01 February 2024
Published
12 February 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2024
Updates
Copyright
© 2024 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.